ECM
AVNS

ExodusPoint Capital Management’s Avanos Medical AVNS Stock Holding History

ExodusPoint Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,100
Closed -$635K – 1955
2020
Q3 		$635K Buy
+19,100
New +$610K 0.01% 891

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ExodusPoint Capital Management's AVNS Position: Q2 2026 in Review

ExodusPoint Capital Management sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 421,504 shares — an estimated $5.91M sold.

ExodusPoint Capital Management first reported a position in AVNS in Q1 2020 and held it in 19 quarters. The position peaked at $15.3M in Q2 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • ExodusPoint Capital Management reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 421,504 Avanos Medical shares in Q2 2026, an estimated $5.91M.
  • ExodusPoint Capital Management first reported a position in Avanos Medical in Q1 2020 and held it in 19 quarters.
  • ExodusPoint Capital Management's Avanos Medical position peaked at $15.3M in Q2 2025.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.